The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
The draw is finished. Select Play to watch it back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback